Stock Events

Regulus Therapeutics (RGLS) Q3 2024 Earnings

RGLS +0.66%
8AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-0.4
-0.32
-0.23
-0.15

Details

Expected EPS
-0.146667
Actual EPS
-0.17
Surprise EPS
-0.02
Surprise Percent
+15.91%

Description

Regulus Therapeutics (RGLS) has reported earnings of -0.17 per share for Q3 2024.

0 Comments

Share your thoughts